Metabolic syndrome: Early identification prevents type II diabetes and cardiovascular disease.
作者信息
Sharma Praveen, Mishra Sandhya
机构信息
Department of Biochemistry, S. M. S. Medical College & Hospital, 302004 Jaipur, India.
出版信息
Indian J Clin Biochem. 2007 Mar;22(1):1-3. doi: 10.1007/BF02912872.
Abstract
摘要
相似文献
1
Metabolic syndrome: Early identification prevents type II diabetes and cardiovascular disease.代谢综合征：早期识别可预防II型糖尿病和心血管疾病。
Indian J Clin Biochem. 2007 Mar;22(1):1-3. doi: 10.1007/BF02912872.
2
Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.代谢综合征或2型糖尿病对高血压患者复发性血管事件发生的影响。
J Hum Hypertens. 2008 May;22(5):358-65. doi: 10.1038/jhh.2008.5. Epub 2008 Feb 14.
3
Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome.2型糖尿病和代谢综合征中心血管风险控制的实践要点
Exp Clin Cardiol. 2007 Summer;12(2):83-6.
4
Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population.新协调定义下代谢综合征相关心血管疾病、中风、缺血性心脏病和糖尿病风险：来自亚洲人群全国代表性纵向数据的发现。
Atherosclerosis. 2010 Dec;213(2):579-85. doi: 10.1016/j.atherosclerosis.2010.09.009. Epub 2010 Sep 18.
5
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?代谢综合征能否改善对 2 型糖尿病和/或心血管疾病风险个体的识别？
Diabetes Care. 2004 Nov;27(11):2676-81. doi: 10.2337/diacare.27.11.2676.
6
Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.代谢综合征和2型糖尿病患者心血管疾病预防的治疗方法。
Curr Opin Cardiol. 2004 Sep;19(5):480-7. doi: 10.1097/01.hco.0000133111.66486.c6.
7
Clinical significance of cardiovascular dysmetabolic syndrome.心血管代谢综合征的临床意义
Curr Control Trials Cardiovasc Med. 2002 Jan 7;3(1):2. doi: 10.1186/1468-6708-3-2.
8
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.代谢综合征能否有效预测心血管疾病和糖尿病？两项前瞻性研究的结果数据。
Lancet. 2008 Jun 7;371(9628):1927-35. doi: 10.1016/S0140-6736(08)60602-9. Epub 2008 May 22.
9
Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.代谢综合征、糖尿病与心血管事件：当前争议与建议
Minerva Cardioangiol. 2006 Apr;54(2):195-214.
10
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.超越低密度脂蛋白：应对2型糖尿病和代谢综合征中的致动脉粥样硬化脂质三联征。
Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005.
引用本文的文献
1
Using easy-to-collect indices to develop and validate models for identifying metabolic syndrome and pre-metabolic syndrome.使用易于收集的指标来开发和验证用于识别代谢综合征和代谢综合征前期的模型。
Front Endocrinol (Lausanne). 2025 Jun 11;16:1587354. doi: 10.3389/fendo.2025.1587354. eCollection 2025.
2
Anti-diabetic Effect of - (Amla) Against Arsenic Induced Metabolic Disorder in Mice.余甘子对砷诱导的小鼠代谢紊乱的抗糖尿病作用
Indian J Clin Biochem. 2020 Apr;35(2):179-187. doi: 10.1007/s12291-019-00820-5. Epub 2019 Mar 25.
3
Microalbuminuria in Obese Young and Middle Aged Population: A Potential Marker of Cardiovascular Risk.肥胖中青年人群中的微量白蛋白尿：心血管风险的潜在标志物
Indian J Clin Biochem. 2016 Jul;31(3):349-52. doi: 10.1007/s12291-016-0563-z. Epub 2016 Apr 1.
4
Association of Resistin with Insulin Resistance and Factors of Metabolic Syndrome in North Indians.北印度人群中抵抗素与胰岛素抵抗及代谢综合征因素的关联
Indian J Clin Biochem. 2015 Jul;30(3):255-62. doi: 10.1007/s12291-014-0459-8. Epub 2014 Aug 24.
5
Study of metabolic syndrome and its risk components in patients attending tertiary care center of uttarakhand.北阿坎德邦三级医疗中心就诊患者的代谢综合征及其风险因素研究
Indian J Clin Biochem. 2014 Jul;29(3):362-6. doi: 10.1007/s12291-013-0366-4. Epub 2013 Jul 28.
6
Hyperinsulinemia predisposes to NAFLD.高胰岛素血症易引发非酒精性脂肪性肝病。
Indian J Clin Biochem. 2008 Apr;23(2):130-5. doi: 10.1007/s12291-008-0030-6. Epub 2008 Jun 11.
7
Prevalence of metabolic syndrome among an urban population in Kenya.肯尼亚城市人口中代谢综合征的流行情况。
Diabetes Care. 2012 Apr;35(4):887-93. doi: 10.2337/dc11-0537. Epub 2012 Feb 28.
本文引用的文献
1
Oxidative stress in metabolic syndrome.代谢综合征中的氧化应激
Indian J Clin Biochem. 2005 Jan;20(1):145-9. doi: 10.1007/BF02893061.
2
The metabolic syndrome.
J Am Coll Cardiol. 2004 Apr 21;43(8):1396-8. doi: 10.1016/j.jacc.2004.01.021.
3
Metabolic syndrome epidemic.代谢综合征流行。
Circulation. 2003 Sep 30;108(13):1552-3. doi: 10.1161/01.CIR.0000093203.00632.2B.
4
Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study.与胰岛素抵抗相关的危险因素分组及其对亚临床动脉粥样硬化的协同作用：社区动脉粥样硬化风险研究
Diabetes. 2002 Oct;51(10):3069-76. doi: 10.2337/diabetes.51.10.3069.
5
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
6
Obesity: preventing and managing the global epidemic. Report of a WHO consultation.肥胖：预防和管理全球流行疾病。世界卫生组织磋商报告。
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
7
Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men.亚洲印度男性中全身性肥胖和上身肥胖与胰岛素抵抗的关系。
J Clin Endocrinol Metab. 1999 Jul;84(7):2329-35. doi: 10.1210/jcem.84.7.5817.
8
Clustering of metabolic factors and coronary heart disease.代谢因素与冠心病的聚类分析。
Arch Intern Med. 1999 May 24;159(10):1104-9. doi: 10.1001/archinte.159.10.1104.
9
Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.亚洲印度男性的身体成分、内脏脂肪、瘦素与胰岛素抵抗
J Clin Endocrinol Metab. 1999 Jan;84(1):137-44. doi: 10.1210/jcem.84.1.5371.
10
Banting lecture 1988. Role of insulin resistance in human disease.1988年班廷讲座。胰岛素抵抗在人类疾病中的作用。
Diabetes. 1988 Dec;37(12):1595-607. doi: 10.2337/diab.37.12.1595.
Zotero 插件